Everything below is real. You can’t buy it here yet.
The CT regulator, statutes, tax stack and track-and-trace on this page are researched and current. We can set up stores in Washington and Arizona today, and CTis not one of them — so there is nothing to sign up for here, and we won’t pretend otherwise. (Washington’s CCRS is still the only track-and-trace we have integrated; Arizona mandates none, which is why it could open without one. A state that mandates one needs that adapter built first.)
DCP
Connecticut DCP-aware dispensary platform
Native compliance hooks for Connecticut Department of Consumer Protection rules. BioTrack CATS traceability (Connecticut's Cannabis and Tracking System, the DCP-administered BioTrack seed-to-sale system), the excise that CHANGES BASE on 2026-10-01 — potency-tier per mg THC through 09-30 (0.625¢ / 2.75¢ / 0.9¢), a flat 10.75% of gross receipts after — plus 6.35% state sales and 3% municipal cannabis tax, DCP reconciliation cadence, and the medical / adult-use lane separation Connecticut requires.
Regulator
Connecticut Department of Consumer Protection (DCP)
https://portal.ct.gov/dcp/medical-marijuana-program ↗Statutes that bite
| Citation | Subject |
|---|---|
| Conn. Gen. Stat. §21a-420 et seq. | Regulation of Adult-Use Cannabis, chapter 420h — the act defined there as RERACA; §21a-420 itself is the definitions section |
| Conn. Gen. Stat. §21a-408 et seq. | Palliative Use of Marijuana, chapter 420f — the medical program; §21a-408 itself is the definitions section |
| RCSA §21a-408 | DCP palliative-use (medical) regulations, §21a-408-1 to -72 — written certifications, patient and caregiver registration, dispensary PMP reporting, producer transportation. Adult-use is NOT in this series |
| Conn. Gen. Stat. §12-330ll | Potency-tier excise tax statute (0.625-2.75¢ per mg THC) |
Tax stack
Excise
Through 2026-09-30: potency-tier excise per mg THC — 0.625¢ (flower) / 2.75¢ (edibles) / 0.9¢ (other), calculated per-product at point of sale rather than as a flat percentage. From 2026-10-01 that model is REPEALED: Public Act 26-68 §264 replaces Conn. Gen. Stat. §12-330ll with a flat 10.75% excise on gross receipts. Same sale, two different bases either side of the date — worth knowing before your September and October numbers refuse to reconcile.
Sales / Use
6.35% Connecticut state sales tax + 3% municipal cannabis tax (mandatory, not optional). Total state-stack: 9.35% on adult-use. MEDICAL IS TAX-FREE, NOT MERELY EXEMPT FROM THE 3%: DCP’s medical-marijuana programme page states participants “have the benefit of tax-free products when purchased from a dispensary facility or hybrid retailer” — so the relief covers the 6.35% as well, and it is scoped to the SELLER’s licence type. Charging a registered patient the state sales tax over-collects 6.35% on every purchase.
Local option
3% municipal cannabis tax is mandatory, applied uniformly statewide — no local-option variance, so there is no city/county rate to look up.
Compliance topics surfaced in-platform
- Age 21+ adult-use / 18+ medical at the register — or an emancipated minor under eighteen, who is a qualifying patient in their own right (Conn. Gen. Stat. §21a-408(20)(C)(ii)); an unemancipated minor patient transacts through the custodial parent or guardian, who the statute requires to control acquisition
- BioTrack CATS-shaped inventory + sales reports on the DCP cadence for licensee submission (CATS is the DCP-administered Cannabis and Tracking System for both medical and adult-use reporting) — direct BioTrack integration is not built
- Potency-tier excise calculation per product — through 2026-09-30 the Department of Revenue Services taxes per mg of total THC AS REFLECTED ON THE PRODUCT LABEL (Conn. Gen. Stat. §12-330ll: 0.625¢ plant material / 2.75¢ edibles / 0.9¢ other), with returns filed to DRS, not DCP. From 2026-10-01 the model changes; see the tax notes on this page
- Patient registry lookup hook (Connecticut Medical Marijuana Patient ID)
- Daily point-of-sale-to-CATS reconciliation plus 7-day physical-inventory reconciliation (DCP Policies & Procedures §21a-421j-5(f)), with every activity logged to CATS within one hour — shaped for DCP record-keeping
- Social-equity license-class flagging (CT prioritized social-equity applicants in the 2022-2023 conversion)
What CannAgent is built toward for CT
- Adult-use + medical product lanes with separate tax stacks
- BioTrack CATS-shaped inventory + sale receipt mirror
- Daily reconciliation report (auto-runs at close)
- Manager write-up assistant configurable to CT labor + DCP rule taxonomy
Coverage here — honestly
Connecticut coverage is written against DCP rules: the bulletins, the excise on both sides of its 2026-10-01 base change — potency-tier per mg THC through 09-30, a flat 10.75% of gross receipts after, under Public Act 26-68 §264 — the 9.35% state stack with no local-option variance, the medical-vs-adult-use 3%-municipal split, and the social-equity license-class topology from the 2022-2023 conversion. We keep it current as the DCP moves, and where something isn’t built for CT yet we say so before you sign — today that means the audit engine will not build a Connecticut filing for October 2026 or later until the gross-receipts basis is settled, because the repeal also strikes the product-class definitions the per-mg basis depended on.
Operator playbooks
Compliance ops playbook
State traceability reconciliation — the daily, weekly, monthly discipline
Buyer scorecard
Picking a cannabis POS: the 7-question scorecard
Migration playbook
POS migration: a 4-week playbook for cannabis dispensaries
Operations deep-dive
Cash discipline at a cannabis dispensary: variance, escalation, audit
Connecticut cannabis retail — common questions
- Who regulates cannabis retail in Connecticut?
- Connecticut Department of Consumer Protection (DCP) is the state cannabis regulator for Connecticut. Official site: https://portal.ct.gov/dcp/medical-marijuana-program.
- What seed-to-sale track-and-trace system does Connecticut use?
- Connecticut uses BioTrack (Helix BioTrack THC) for seed-to-sale traceability. CannAgent maps its inventory and transfer records to the fields BioTrack requires.
- What cannabis taxes apply to retail in Connecticut?
- Through 2026-09-30: potency-tier excise per mg THC — 0.625¢ (flower) / 2.75¢ (edibles) / 0.9¢ (other), calculated per-product at point of sale rather than as a flat percentage. From 2026-10-01 that model is REPEALED: Public Act 26-68 §264 replaces Conn. Gen. Stat. §12-330ll with a flat 10.75% excise on gross receipts. Same sale, two different bases either side of the date — worth knowing before your September and October numbers refuse to reconcile. 6.35% Connecticut state sales tax + 3% municipal cannabis tax (mandatory, not optional). Total state-stack: 9.35% on adult-use. MEDICAL IS TAX-FREE, NOT MERELY EXEMPT FROM THE 3%: DCP’s medical-marijuana programme page states participants “have the benefit of tax-free products when purchased from a dispensary facility or hybrid retailer” — so the relief covers the 6.35% as well, and it is scoped to the SELLER’s licence type. Charging a registered patient the state sales tax over-collects 6.35% on every purchase. 3% municipal cannabis tax is mandatory, applied uniformly statewide — no local-option variance, so there is no city/county rate to look up.
- Is CannAgent available for Connecticut dispensaries?
- Regulatory-summary coverage for Connecticut is current; engineering capacity opens as operator demand lands. There is no CT queue to join yet — read the rules here, and come back when you want a second opinion on a CT question.
Other states
Washington
Colorado
California
Oregon
Michigan
New Jersey
New York
Massachusetts
Illinois
Missouri
Nevada
Arizona
Maryland
Oklahoma
Maine
Rhode Island
New Mexico
Vermont
Minnesota
Delaware
Alaska
Montana
Ohio
We know Connecticut’s rules. We don’t sell here yet.
Everything above is researched against the DCP and kept current. We can only set up stores in Washington and Arizona today, so there is no quote to give you and no queue to join. Read the rules, keep the page, and come back when you want a second opinion on CT.